The serum LECT2 level was significantly higher in patients with BA compared with the control group [32.03 ng/ml (25.42, 40.47) vs. 20.37 ng/ml (17.07, 22.37), p < 0.0001; Figure 3A]. This evidence concerns the gene LECT2 and breast angiosarcoma.